PECAM1 and neoplasm: There is significantly increased co-expression of the CD31 and VCAM1 in tumor areas compared to that in adjacent normal brain tissue or non-injected contralateral normal brain (scores 3.2 vs 1, p = 0.0004, Left panels in Fig. 5e, f).